Authors:
BRISTOW LJ
COOK GP
PATEL S
CURTIS N
MAWER I
KULAGOWSKI JJ
Citation: Lj. Bristow et al., DISCRIMINATIVE STIMULUS PROPERTIES OF THE PUTATIVE DOPAMINE D-3 RECEPTOR AGONIST, (-PD-128907 - ROLE OF PRESYNAPTIC DOPAMINE D-2 AUTORECEPTORS()), Neuropharmacology, 37(6), 1998, pp. 793-802
Authors:
PATEL S
MARWOOD R
CHAPMAN KL
PATEL S
BRISTOW LJ
KULAGOWSKI JJ
FREEDMAN SB
Citation: S. Patel et al., PROPERTIES AND POTENTIAL APPLICATIONS OF D3 AND D4 RECEPTOR ANTAGONISTS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 43-43
Citation: F. Murray et al., THE SELECTIVE 5-HT2A RECEPTOR ANTAGONIST MDL-100,907 ATTENUATES THE BEHAVIORAL AND NEUROCHEMICAL EFFECTS OF PCP IN RODENTS, British Journal of Pharmacology, 123, 1998, pp. 241-241
Authors:
BRISTOW LJ
KRAMER MS
KULAGOWSKI J
PATEL S
RAGAN CI
SEABROOK GR
Citation: Lj. Bristow et al., SCHIZOPHRENIA AND L-745,870, A NOVEL DOPAMINE D4 RECEPTOR ANTAGONIST, Trends in pharmacological sciences, 18(6), 1997, pp. 186-188
Authors:
BRISTOW LJ
COLLINSON N
COOK GP
CURTIS N
FREEDMAN SB
KULAGOWSKI JJ
LEESON PD
PATEL S
RAGAN CI
RIDGILL M
SAYWELL KL
TRICKLEBANK MD
Citation: Lj. Bristow et al., L-745,870, A SUBTYPE-SELECTIVE DOPAMINE-D4 RECEPTOR ANTAGONIST, DOES NOT EXHIBIT A NEUROLEPTIC-LIKE PROFILE IN RODENT BEHAVIORAL-TESTS, The Journal of pharmacology and experimental therapeutics, 283(3), 1997, pp. 1256-1263
Authors:
PATEL S
FREEDMAN S
CHAPMAN KL
EMMS F
FLETCHER AE
KNOWLES M
MARWOOD R
MCALLISTER G
MYERS J
PATEL S
CURTIS N
KULAGOWSKI JJ
LEESON PD
RIDGILL M
GRAHAM M
MATHESON S
RATHBONE D
WATT AP
BRISTOW LJ
RUPNIAK NMJ
BASKIN E
LYNCH JJ
RAGAN CI
Citation: S. Patel et al., BIOLOGICAL PROFILE OF L-745,870, A SELECTIVE ANTAGONIST WITH HIGH-AFFINITY FOR THE DOPAMINE-D4 RECEPTOR, The Journal of pharmacology and experimental therapeutics, 283(2), 1997, pp. 636-647
Authors:
BRISTOW LJ
GAY JC
COOK GP
PATEL S
EMMS F
MAWER J
KULAGOWSKI JJ
Citation: Lj. Bristow et al., DISCRIMINATIVE STIMULUS PROPERTIES OF THE PUTATIVE DOPAMINE D-3 RECEPTOR AGONIST, (-PD-128907, IN THE RAT()), British Journal of Pharmacology, 120, 1997, pp. 245-245
Authors:
BRISTOW LJ
COOK GP
GAY JC
KULAGOWSKI JJ
LANDON L
MURRAY F
SAYWELL KL
YOUNG L
HUTSON PH
Citation: Lj. Bristow et al., THE BEHAVIORAL AND NEUROCHEMICAL PROFILE OF THE PUTATIVE DOPAMINE D-3RECEPTOR AGONIST, (-PD-128907, IN THE RAT()), Neuropharmacology, 35(3), 1996, pp. 285-294
Authors:
BRISTOW LJ
HUTSON PH
KULAGOWSKI JJ
LEESON PD
MATHESON S
MURRAY F
RATHBONE D
SAYWELL KL
THORN L
WATT AP
TRICKLEBANK MD
Citation: Lj. Bristow et al., ANTICONVULSANT AND BEHAVIORAL PROFILE OF L-701,324, A POTENT, ORALLY-ACTIVE ANTAGONIST AT THE GLYCINE MODULATORY SITE ON THE N-METHYL-D-ASPARTATE RECEPTOR COMPLEX, The Journal of pharmacology and experimental therapeutics, 279(2), 1996, pp. 492-501
Authors:
BRISTOW LJ
FLATMAN KL
HUTSON PH
KULAGOWSKI JJ
LEESON PD
YOUNG L
TRICKLEBANK MD
Citation: Lj. Bristow et al., THE ATYPICAL NEUROLEPTIC PROFILE OF THE GLYCINE N-METHYL-D-ASPARTATE RECEPTOR ANTAGONIST, L-701,324, IN RODENTS/, The Journal of pharmacology and experimental therapeutics, 277(2), 1996, pp. 578-585
Authors:
BRISTOW LJ
SAYWELL KL
COOK GP
KULAGOWSKI JJ
LEESON PD
RAGAN CI
TRICKLEBANK MD
Citation: Lj. Bristow et al., LACK OF EFFECT OF THE DOPAMINE D-4 RECEPTOR ANTAGONIST, L-745,870 ON AMPHETAMINE-INDUCED BEHAVIORS IN RODENTS, British Journal of Pharmacology, 119, 1996, pp. 210-210
Citation: L. Young et Lj. Bristow, THE GLYCINE NMDA RECEPTOR ANTAGONIST, L-701,324, REVERSES ISOLATION REARING-INDUCED HYPERLOCOMOTION IN THE RAT, British Journal of Pharmacology, 117, 1996, pp. 172-172
Citation: Kl. Saywell et al., THE GLYCINE NMDA RECEPTOR ANTAGONIST, L-701,324, ATTENUATES THE DEFICIT IN PREPULSE INHIBITION OF ACOUSTIC STARTLE RESPONDING INDUCED BY AMPHETAMINE IN THE RAT, British Journal of Pharmacology, 117, 1996, pp. 173-173
Authors:
BRISTOW LJ
LANDON L
SAYWELL KL
TRICKLEBANK MD
Citation: Lj. Bristow et al., THE GLYCINE NMDA RECEPTOR ANTAGONIST, L-701,324 REVERSES ISOLATION-INDUCED DEFICITS IN PREPULSE INHIBITION IN THE RAT, Psychopharmacology, 118(2), 1995, pp. 230-232
Authors:
HUTSON PH
BRISTOW LJ
CUNNINGHAM JR
HOGG JE
LONGMORE J
MURRAY F
PEARCE D
RAZZAQUE Z
SAYWELL K
TRICKLEBANK MD
YOUNG L
Citation: Ph. Hutson et al., THE EFFECTS OF GR127935, A PUTATIVE 5-HT1D RECEPTOR ANTAGONIST, ON BRAIN 5-HT METABOLISM, EXTRACELLULAR 5-HT CONCENTRATION AND BEHAVIOR IN THE GUINEA-PIG, Neuropharmacology, 34(4), 1995, pp. 383-392
Citation: F. Murray et al., INTRACORTICAL INFUSION OF NMDA RECEPTOR ANTAGONISTS - NEUROCHEMICAL EFFECTS, British Journal of Pharmacology, 116, 1995, pp. 114-114
Citation: Jc. Gay et al., HYPERACTIVITY INDUCED BY COMPETITIVE BUT NOT GLYCINE NMDA RECEPTOR ANTAGONISTS FOLLOWING INJECTION INTO RAT MEDIAL PREFRONTAL CORTEX/, British Journal of Pharmacology, 116, 1995, pp. 115-115
Authors:
SAYWELL K
BRISTOW LJ
FOSTER AC
GRIMWOOD S
HILL RG
HUTSON PH
KULAGOWSKI J
LEESON PD
TRICKLEBANK MD
Citation: K. Saywell et al., THE PHARMACOLOGICAL PROFILE OF THE GLYCINE NMDA RECEPTOR ANTAGONIST, L-701,324/, British Journal of Pharmacology, 114, 1995, pp. 320-320
Authors:
BRISTOW LJ
FLATMAN KL
YOUNG L
THORN L
HUTSON PH
TRICKLEBANK MD
Citation: Lj. Bristow et al., THE GLYCINE NMDA RECEPTOR ANTAGONIST, L-701,324, BLOCKS THE NEUROCHEMICAL AND BEHAVIORAL-EFFECTS OF AMPHETAMINE IN RODENTS/, British Journal of Pharmacology, 114, 1995, pp. 321-321
Authors:
HUTSON PH
THORN L
BRISTOW LJ
TRICKLEBANK MD
Citation: Ph. Hutson et al., L-701,324, A GLYCINE NMDA RECEPTOR ANTAGONIST, ATTENUATES ACTIVATION OF THE MESOLIMBIC DOPAMINE SYSTEM BY PHENCYCLIDINE/, British Journal of Pharmacology, 114, 1995, pp. 322-322
Authors:
BRISTOW LJ
LANDON L
SAYWELL KL
TRICKLEBANK MD
Citation: Lj. Bristow et al., THE GLYCINE NMDA RECEPTOR ANTAGONIST, L-701,324, REVERSES ISOLATION-INDUCED DEFICITS IN PREPULSE INHIBITION OF THE ACOUSTIC STARTLE RESPONSE IN THE RAT/, British Journal of Pharmacology, 114, 1995, pp. 323-323
Authors:
BRISTOW LJ
THORN L
TRICKLEBANK MD
HUTSON PH
Citation: Lj. Bristow et al., COMPETITIVE NMDA RECEPTOR ANTAGONISTS ATTENUATE THE BEHAVIORAL AND NEUROCHEMICAL EFFECTS OF AMPHETAMINE IN MICE, European journal of pharmacology, 264(3), 1994, pp. 353-359